BioAge Labs Statistics
NASDAQ: BIOAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.28-0.43 (-9.13%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioAge Labs by the numbers
BioAge Labs has a market capitalization of $196.7 million based on 45.95M shares outstanding. With trailing EPS of $-2.56, BioAge Labs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.7% below its 50-day average and 71.0% below its 200-day average.
Average daily trading volume is 740.06K shares, or about $3.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BIOA valuation vs. peer median
| Metric | BIOA | Peer median | Difference |
|---|---|---|---|
| Market cap | $196.67M | $197.54M | -0% |
| Avg. volume | 740.06K | 244.05K | +203% |
Peer median across 8 companies: YARW, NGEN, ACIU, ANTX, DRUG, BCYC, FTH, RNAC.
Valuation
- Market cap
- $196.67M
- Price / sales (latest FY)
- 21.86
- EPS (TTM)
- $-2.56
- Shares outstanding
- 45.95M
Price and trading
- Previous close
- 4.71
- Open
- 4.60
- Day range
- 4.24 – 4.77
- 52-week range
- 4.24 – 25.96
- 52-week change
- -50.52%
- Beta
- —
- Volume
- 632.10K
- Average volume
- 740.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 196.67M
- Forward Pe
- -1.59
- Eps
- -2.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.96
- Week52 Low
- 4.24
- Avg Volume
- 740.06K
- Shares Outstanding
- 45.95M
- Ma50
- 6.18
- Ma200
- 14.74
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -83.51%
- Pct From52w Low
- 1.06%